Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-140498
Filing Date
2020-05-12
Accepted
2020-05-12 16:35:26
Documents
31
Period of Report
2020-03-29

Document Format Files

Seq Description Document Type Size
1 10-Q d792614d10q.htm   iXBRL 10-Q 441551
2 EX-2.1 d792614dex21.htm EX-2.1 9934
3 EX-31.1 d792614dex311.htm EX-31.1 6739
4 EX-31.2 d792614dex312.htm EX-31.2 6747
5 EX-32.1 d792614dex321.htm EX-32.1 3345
6 EX-32.2 d792614dex322.htm EX-32.2 3415
12 GRAPHIC g792614g85i86.jpg GRAPHIC 18356
  Complete submission text file 0001193125-20-140498.txt   1238726

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ck0001792044-20200329.xsd EX-101.SCH 10430
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001792044-20200329_cal.xml EX-101.CAL 14320
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001792044-20200329_def.xml EX-101.DEF 30483
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001792044-20200329_lab.xml EX-101.LAB 78603
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001792044-20200329_pre.xml EX-101.PRE 66625
23 EXTRACTED XBRL INSTANCE DOCUMENT d792614d10q_htm.xml XML 59807
Mailing Address 235 EAST 42ND STREET NEW YORK NY 10017
Business Address 235 EAST 42ND STREET NEW YORK NY 10017 (212) 733-2323
Upjohn Inc (Filer) CIK: 0001792044 (see all company filings)

EIN.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56114 | Film No.: 20869573
SIC: 2834 Pharmaceutical Preparations